HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Prostaglandin E1 improved the function of transplanted fatty liver in a rat reduced-size-liver transplantation model under conditions of permissible cold preservation.

Abstract
The aim of this study was to determine whether the minimum necessary volume of a moderate fatty liver graft was similar to the normal liver volume and to elucidate means for improving the function of the transplanted fatty liver if it were inferior in volume to a normal liver under conditions of permissible cold preservation. Nine-week-old male Wistar rats were used. Normal rat chow was fed to the normal liver group, and fat-enriched rat chow was fed to the fatty liver group for 4 weeks to induce a moderately fatty liver. Liver transplantation with various volumes of reduced-size grafts, including whole liver graft (100%LT), 70% volume graft (70%LT), and 30% volume graft (30%LT), was performed with both groups of rats as donors. All procedures were performed under the conditions of 2-hour cold preservation. All rats with an implanted normal liver were surviving at 7 days after the operation regardless of the graft volume (100%LT, 5 of 5; 70%LT, 5 of 5; 30%LT, 5/5). In contrast, the survival rates decreased according to the graft volume in rats implanted with fatty livers (100%LT, 8 of 8; 70%LT, 5 of 8; 30%LT, 2/8). To improve the survival of 30%LT with fatty liver, we employed two potent inhibitors of ischemia-reperfusion injury: FK506 and prostaglandin E1. Though FK506 had no advantageous effect, prostaglandin E1 significantly improved the survival rate and diminished serum levels of alanine aminotransferase and hyaluronic acid. In conclusion, the volume of graft necessary for successful transplantation is larger in fatty livers than in normal livers in permissible cold preservation. Also, prostaglandin E1 protects grafts against ischemia-reperfusion injury and improves the functioning of a transplanted fatty liver.
AuthorsDaisuke Morioka, Toru Kubota, Hitoshi Sekido, Kenichi Matsuo, Shuji Saito, Yasushi Ichikawa, Itaru Endo, Shinji Togo, Hiroshi Shimada
JournalLiver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society (Liver Transpl) Vol. 9 Issue 1 Pg. 79-86 (Jan 2003) ISSN: 1527-6465 [Print] United States
PMID12514777 (Publication Type: Journal Article)
Chemical References
  • Immunosuppressive Agents
  • Hyaluronic Acid
  • Alanine Transaminase
  • Alprostadil
  • Tacrolimus
Topics
  • Alanine Transaminase (blood)
  • Alprostadil (therapeutic use)
  • Animals
  • Fatty Liver (physiopathology)
  • Hyaluronic Acid (blood)
  • Immunosuppressive Agents (therapeutic use)
  • Liver (pathology)
  • Liver Transplantation (methods, mortality, physiology)
  • Male
  • Models, Animal
  • Organ Preservation
  • Rats
  • Rats, Wistar
  • Reperfusion Injury (prevention & control)
  • Tacrolimus (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: